Icon Limited, a leading global provider in the clinical research industry, is headquartered in Great Britain. Founded in 1990, the company has established itself as a key player in the development of innovative solutions for the pharmaceutical, biotechnology, and medical device sectors. With a strong presence across Europe, North America, and Asia, Icon Limited offers a comprehensive range of services, including clinical trial management, data analytics, and regulatory consulting. What sets Icon Limited apart is its commitment to leveraging advanced technology and deep industry expertise to enhance trial efficiency and patient engagement. The company has achieved significant milestones, including numerous successful drug approvals and partnerships with top-tier clients. Recognised for its excellence, Icon Limited continues to solidify its market position as a trusted partner in the pursuit of medical advancements.
How does Icon Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Icon Limited's score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Icon Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is classified as a current subsidiary and inherits its climate commitments and data from its parent organization, which is not specified in the available information. Despite the lack of specific emissions data, Icon Limited's climate commitments and reduction initiatives are not detailed in the provided information. There are no documented reduction targets or initiatives such as those from the Science Based Targets initiative (SBTi) or other climate pledges. As a current subsidiary, Icon Limited may align its sustainability efforts with broader corporate strategies from its parent organization, but specific details on these initiatives or targets are not available. The company appears to be in the early stages of formalising its climate strategy and emissions reporting.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Icon Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
